drugset / Trial / NCT06868745

Effects of Melatonin Supplementation on Sleep Quality in Patients With Advanced Glaucoma

NCT06868745

Completed 64 enrolled University of Sao Paulo
RandomizedParallel-groupTriple-blindSupportive care

Summary

A prospective, randomized, parallel, crossover, double-blind therapeutic clinical trial was conducted in accordance with the principles of the Resolution nº 466/12 of the National Health Council and was approved by the Ethics and Research Committee of the Federal University of São Paulo, project CEP/UNIFESP n:1023/2020, CAAE: 36946620.9.0000.5505. Written informed consent was obtained from all participants. The study was conducted at the Glaucoma Division and the Department of Psychobiology at the Federal University of São Paulo - UNIFESP/EPM and at the Laser Vision Eye Hospital - Santos/SP between May/2022 and July/2023.

Timeline

Start
2022-05-04
Primary completion
2023-07-20
Completion
2024-06-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 5 mg